Dilakian E A, Vinokurova S V, Zhurbitskaia V A, Komissarova E V, Topol' L Z, Kiselev F L, Solov'eva N I
Institute of Biomedical Chemistry RAMS, Moscow, Russia.
Vopr Med Khim. 1998 Jan-Feb;44(1):35-42.
Expression of cysteine proteinases, cathepsins L and B, and their inhibitors was studied out in three model systems of rat embryo fibroblasts, sequentially immortalized and transformed by different genes. In Model I rat embryo fibroblasts were immortalized with DNA of early region of simian adenovirus SA7 (clone REF-1) and then transformed by c-Ha-ras oncogene (REF-2EJ; malignant transformation). In Model II and III, the immortalized fibroblasts (clone IE5) were obtained by transfection with the polyoma virus LT gene and the clone IE5 used lost this gene; the malignant transformation was achieved by transfection with the E7 gene (clone trF8; Model II) and E6/E7 genes ¿clone A5E5(pC7-1); Model III]¿ of human papilloma virus types 16 and 18 respectively. In Model I, the increase in the total cathepsin L and B activity was correlated with the stages of transformation, at the same time, in Models II and III, this activity in immortalized IE5 fibroblasts was higher than at transformation stage. The activity of cathepsin L in lysates of transformed fibroblasts--REF-2EJ, significantly exceeded this activity both in transformed cells trF8 and A5E5(pC7-1)(6- and 10-fold, respectively). In cell cultures of Models I and II, the increases in secreted activity of cathepsins L and B were correlated with the stages of fibroblasts transformation, but in cultures of Model III, this activity at the stage of malignant transformation was lower than that the stage of immortalization. Therefore, the activities of cathepsins L and B were expressed to varying degrees at different stages of oncogenic transformation and the expression of their activities were dependent on type of transforming gene. It was established that changes in proteolytic potential were correlated with differences in the transforming phenotype of cell clones. An endogenous inhibitor(s) of cysteine proteinases was found in conditioned media of all type cell cultures. Expression and inhibitory properties of this inhibitor(s) were different at distinct stages of transformation.
在大鼠胚胎成纤维细胞的三种模型系统中,研究了半胱氨酸蛋白酶、组织蛋白酶L和B及其抑制剂的表达情况。这些模型系统通过不同基因依次进行永生化和转化。在模型I中,大鼠胚胎成纤维细胞用猿猴腺病毒SA7早期区域的DNA(克隆REF-1)进行永生化,然后用c-Ha-ras癌基因进行转化(REF-2EJ;恶性转化)。在模型II和III中,通过用多瘤病毒LT基因转染获得永生化成纤维细胞(克隆IE5),且所用的克隆IE5丢失了该基因;分别用16型和18型人乳头瘤病毒的E7基因(克隆trF8;模型II)和E6/E7基因(克隆A5E5(pC7-1);模型III)进行转染实现恶性转化。在模型I中,组织蛋白酶L和B的总活性增加与转化阶段相关,同时,在模型II和III中,永生化的IE5成纤维细胞中的这种活性高于转化阶段。转化的成纤维细胞(REF-2EJ)裂解物中组织蛋白酶L的活性显著超过转化细胞trF8和A5E5(pC7-1)中的该活性(分别为6倍和10倍)。在模型I和II的细胞培养物中,组织蛋白酶L和B的分泌活性增加与成纤维细胞转化阶段相关,但在模型III的培养物中,恶性转化阶段的这种活性低于永生化阶段。因此,组织蛋白酶L和B的活性在致癌转化的不同阶段有不同程度的表达,其活性表达取决于转化基因的类型。已确定蛋白水解潜能的变化与细胞克隆转化表型的差异相关。在所有类型细胞培养物的条件培养基中发现了一种半胱氨酸蛋白酶的内源性抑制剂。该抑制剂在转化的不同阶段的表达和抑制特性不同。